Skip to content
10-Q

Quarterly Report

Oncotelic Therapeutics, Inc. OTLC

0001641172-25-023568

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 434.93M sh
Shares Diluted Q2 2025 · Jun 30, 2025 452.81M sh
Shares Diluted Q2 2025 · Jun 30, 2025 407.86M sh
Shares Diluted Q2 2025 · Jun 30, 2024 401.6M sh
Shares Diluted Q2 2025 · Jun 30, 2024 401.49M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$293.11K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$493.19K
Short Term Debt Q2 2025 · Jun 30, 2025 $2.72M
Short Term Debt Q2 2025 · Dec 31, 2024 $2.42M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $88.02K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $86.13K
Stockholders Equity Q2 2025 · Jun 30, 2025 $8.3M
Stockholders Equity Q2 2025 · Dec 31, 2024 $8.25M
Current Liabilities Q2 2025 · Jun 30, 2025 $19.29M
Current Liabilities Q2 2025 · Dec 31, 2024 $19.2M
Total Liabilities Q2 2025 · Jun 30, 2025 $19.29M
Total Liabilities Q2 2025 · Dec 31, 2024 $19.2M
Current Assets Q2 2025 · Jun 30, 2025 $137.59K
Current Assets Q2 2025 · Dec 31, 2024 $134.21K
Total Assets Q2 2025 · Jun 30, 2025 $26.68M
Total Assets Q2 2025 · Dec 31, 2024 $26.68M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Sga Expense Q2 2025 · Jun 30, 2025 $65.67K
Sga Expense Q2 2025 · Jun 30, 2025 $166.47K
Sga Expense Q2 2025 · Jun 30, 2024 $96.33K
Sga Expense Q2 2025 · Jun 30, 2024 $263.07K
Rd Expense Q2 2025 · Jun 30, 2025 $297
Rd Expense Q2 2025 · Jun 30, 2025 $594
Rd Expense Q2 2025 · Jun 30, 2024 $252
Rd Expense Q2 2025 · Jun 30, 2024 $732
Net Income Q2 2025 · Jun 30, 2025 $277.86K
Net Income Q2 2025 · Jun 30, 2025 −$20.86K
Net Income Q2 2025 · Jun 30, 2024 −$209.84K
Net Income Q2 2025 · Jun 30, 2024 −$618.51K
Operating Income Q2 2025 · Jun 30, 2025 −$65.97K
Operating Income Q2 2025 · Jun 30, 2025 −$167.07K
Operating Income Q2 2025 · Jun 30, 2024 −$96.58K
Operating Income Q2 2025 · Jun 30, 2024 −$263.8K